Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Biotech stocks plunge as FDA's Peter Marks resigns over RFK Jr. dispute, Moderna and Beam Therapeutics hit hard
02:25pm, Monday, 31'st Mar 2025
Biotech investors are grappling with fresh uncertainty following the abrupt resignation of Dr. Peter Marks, a key figure in the US Food and Drug Administration.
Why Moderna Stock Is Plummeting Today
01:58pm, Monday, 31'st Mar 2025
Shares of Moderna (MRNA -9.35%) are falling on Monday. The company's stock lost 7.9% as of 1:30 p.m.
Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
10:13am, Monday, 31'st Mar 2025
Shares of vaccine makers Moderna and Novavax, along with a range of other biotech companies, fell after the resignation of key FDA official Peter Marks. Marks stepped down in protest of Health and Hum
Biotech stocks tumble on reports FDA's top vaccine regulator to leave
07:25am, Monday, 31'st Mar 2025
Shares of U.S. biotech companies fell as much as 10% premarket on Monday following reports that a top vaccine official at the U.S. Food and Drug Administration had resigned, fanning worries over slowe
Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults
07:00am, Monday, 31'st Mar 2025
CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA-1345)
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
06:44am, Saturday, 22'nd Mar 2025
Valuation always matters in investing. And sometimes you can find stocks that are especially great bargains.
Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It
05:45pm, Friday, 21'st Mar 2025
Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
4 Things You Need to Know if You Buy Moderna Stock Today
08:45am, Thursday, 20'th Mar 2025
It's been nearly five years since Moderna (MRNA -1.60%) emerged as a biotech industry disruptor, with its COVID-19 vaccine playing a landmark role in tackling the global pandemic in late 2020. Despite
2 No-Brainer Biotech Stocks to Buy Right Now
06:10pm, Wednesday, 19'th Mar 2025
Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock might soar as investors bet on the company's cutting-edge technology through
Moderna Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell?
11:16am, Tuesday, 18'th Mar 2025
Given the uncertainty around its top-line growth, short-term investors should exercise caution when investing in MRNA stock.
mRNA Vaccines Market Trends and Competition Analysis 2025-2030: Revenues are Projected to Nearly Double, Growing by ~$8 Billion
05:20am, Tuesday, 18'th Mar 2025
Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "mRNA Vaccines Market by Technology Type, Route of Administration, Manufacturing Process, Vaccine Classification, Application Areas, End-User, Distributi
Moderna (MRNA) Advances But Underperforms Market: Key Facts
06:55pm, Monday, 17'th Mar 2025
In the latest trading session, Moderna (MRNA) closed at $34.71, marking a +0.26% move from the previous day.
Down 93%, Is It Finally Time to Buy Moderna?
04:38am, Saturday, 15'th Mar 2025
As we near the five-year anniversary of the COVID-19 pandemic, it's a good time to revisit the drugmaker stock that was top of mind back then. A few years ago, Moderna (MRNA 0.93%) stock soared on the
Moderna (MRNA) Presents at Barclays 27th Annual Global Healthcare Conference (Transcript)
03:59pm, Tuesday, 11'th Mar 2025
Moderna (NASDAQ:MRNA ) Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ET Company Participants Rose Loughlin - EVP of Research Lavina Talukdar - SVP, Head of IR Conference Cal
Insiders Are Loading Up on These 4 Biotech Stocks Now
08:45am, Tuesday, 11'th Mar 2025
Things are heating up in the biotechnology space, with a flurry of recent initial public offerings and some notable insider purchases of the past week or so.
